ITOS
Iteos Therapeutics, Inc.
Director David Hallal sold $597K of Iteos Therapeutics, Inc.
Sold$597,214
$20.17Price
29,615Shares
−100%Stake
What ITOS did after the filing
- The stock from Mon, Jun 13 open, $17.00
- +51.2%
- S&P 500, same days
- +6.0%
Measured over 30 trading days, to the Jul 27 close.
Traded Wed, Jun 8. Filed Fri, Jun 10, 7:51 PM ET, after the close. Returns use the Jun 13 open and the Jul 27 close. Not investment advice.